Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is likely that low recruitment resulted from a confluence of cohort-specific barriers (e.g. busy life stage, high rates of depression; 21, 23, [33] and context-specific barriers (e.g. study fatigue from concurrent NDSS-supported research programs, personal communication, D. Rae, National Operations Manager NDSS).”
From Effect of a tailored leaflet to promote diabetic retinopathy screening among young adults with type 2 diabetes: a randomised controlled trial (2020) · cites this paper as [23]
In the citing paper
“It is likely that recruitment was impacted by a range of challenges typically specific to young adults with T2D, such as social disadvantage, disengagement with existing services, and complex psychosocial and health needs [44, 46, 47, 82].”
From A tailored intervention to promote uptake of retinal screening among young adults with type 2 diabetes - an intervention mapping approach (2018) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of diabetes in youth in the United States
SEARCH for Diabetes in Youth Study Group*, T. W. G. F. T. (2007) · JAMA · doi:10.1001/jama.297.24.2716 · Cited by 991
SEARCH for Diabetes in Youth Study Group (2006) · Pediatrics · doi:10.1542/peds.2006-0690 · Cited by 726
Effect of Metformin in Pediatric Patients With Type 2 Diabetes
Jones, K. L., Arslanian, S., Peterokova, V. A., Park, J.-S., & Tomlinson, M. J. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.89 · Cited by 392
Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents
Copeland, K. C., Silverstein, J., Moore, K. R., Prazar, G. E., Raymer, T., Shiffman, R. N., Springer, S. C., Thaker, V. V., Anderson, M., Spann, S. J., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3494 · Cited by 323
Self-citationTODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288
Research works printed but not linked: 16
- Cefalu W. TODAY reflects on the changing “faces” of type 2 diabetes. Diabetes Care. 2013;36:1732–4. · DOI
- TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247–56. This article reports the primary findings of the TODAY study, the first large trial examining the efficacy of medication and lifestyle intervention in youth-onset T2D. · DOI · Paper page
- Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427–43. · DOI · Paper page
- Brown JB, Conner C, Nichols GA. Secondary failure of metformin monotherapy in clinical practice. Diabetes Care. 2010;33:501–6. · DOI · Paper page
- TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36:1735–41. · DOI · Paper page
- Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care. 2007;30:790–4. · DOI · Paper page
- Baranowski T, Cooper DM, Harrell J, Hirst K, Kaufman FR, Goran M, et al. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care. 2006;29:212–7. · DOI · Paper page
- Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010;33:1970–5. · DOI · Paper page
- Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Barrett T, et al. Type 2 diabetes in the child and adolescent. Pediatr Diabetes. 2014;15 Suppl 20:26–46. Guidelines from the International Society for Pediatric and Adolescent Diabetes regarding the diagnosis and management of T2D in adolescents. · DOI · Paper page
- Laffel L, Chang N, Grey M, Hale D, Higgins L, Hirst K, et al. Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study. Pediatr Diabetes. 2012;13:369–75. · DOI
- Hudson OD, Nunez M, Shaibi GQ. Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. BMC Pediatr. 2012;12:174. · DOI
- Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry. 2013;70:1067–75. · DOI · Paper page
- Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159–67. This article provides in-depth information regarding the characteristics of the population with youth-onset T2D. · DOI · Paper page
- Bacha F, Pyle L, Nadeau K, Cuttler L, Goland R, Haymond M, et al. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012;13:376–83. · DOI · Paper page
- Reinehr T, Kiess W, Kapellen T, Wiegand S, Holl RW, APV and DPV Wiss Study Group and German Competence Net Obesity. Children with diabetes mellitus type 2 in Europe: an underserved population. Arch Dis Child. 2010;95:954. · DOI · Paper page
- TODAY Study Group, Wilfley D, Berkowitz R, Goebel-Fabbri A, Hirst K, Ievers-Landis C, et al. Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the TODAY study. Diabetes Care. 2011;34:858–60. · DOI · Paper page
Cited by
Long-term complications in youth-onset type 2 diabetes
TODAY Study Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100165 · Cited by 546
Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities
Nadeau, K. J., Anderson, B. J., Berg, E. G., Chiang, J. L., Chou, H., Copeland, K. C., Hannon, T. S., Huang, T. T.-K., Lynch, J. L., Powell, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1066 · Cited by 381
“Furthermore, these complexities hinder successful recruitment into and completion of research programs (1), leaving large gaps in knowledge on pathophysiology and treatment optimization.”
BackgroundSelf-citationLake, A. J., Browne, J. L., Abraham, C., Tumino, D., Hines, C., Rees, G., & Speight, J. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3188-5 · Cited by 82
Lake, A. J., Hateley-Browne, J. L., Rees, G., & Speight, J. (2020) · BMC Ophthalmology · doi:10.1186/s12886-020-1311-y · Cited by 18
Metadata
- Authors
- Zeitler, P., Chou, H. S., Copeland, K. C., & Geffner, M.
- Venue
- Current Diabetes Reports
- Published
- 2015-03-18
- Volume
- 15
- Issue
- 5
- ISSN
- 1534-4827
- 1539-0829
- Cited by
- 26
- References
- 6
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options. https://app.cochat.ai/papers/10.1007/s11892-015-0597-2
- The paper
- Zeitler, P., Chou, H. S., Copeland, K. C., & Geffner, M. (2015). Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options. Current Diabetes Reports. https://doi.org/10.1007/s11892-015-0597-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.